Search research articles
Contact Us
Filters
Showing results (131-140 of 161) with videos related to
Page
of 17
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 8, 2024
A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome
Desiré Casares-Marfil, Manuel Martínez-Bueno, Maria Orietta Borghi, et al.
The Journal of Clinical Investigation
|
October 28, 2021
The intersection of COVID-19 and autoimmunity
Jason S Knight, Roberto Caricchio, Jean-Laurent Casanova, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 12, 2023
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study
Elena Gkrouzman, Rohan Willis, Danieli Andrade, et al.
The Journal of Clinical Investigation
|
June 13, 2024
Neutrophil glucose flux as a therapeutic target in antiphospholipid syndrome
Ajay Tambralli, Alyssa Harbaugh, Somanathapura K NaveenKumar, et al.
JCI Insight
|
August 22, 2023
Key patient demographics shape innate immune topography in noncritical hypoxic COVID-19 pneumonia
Allison C Billi, Rachael Wasikowski, Feiyang Ma, et al.
Frontiers in Immunology
|
April 27, 2026
Correction: A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry
Alexander Pine, Ayesha Butt, Laura Andreoli, et al.
Nature Communications
|
February 7, 2017
DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis
Nirit Mor-Vaknin, Anjan Saha, Maureen Legendre, et al.
Frontiers in Immunology
|
November 3, 2025
A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry
Alexander Pine, Ayesha Butt, Laura Andreoli, et al.
Arthritis Care & Research
|
April 19, 2018
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository
Ozan Unlu, Doruk Erkan, Medha Barbhaiya, et al.
The Journal of Experimental Medicine
|
April 18, 2020
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
Betsy J Barnes, Jose M Adrover, Amelia Baxter-Stoltzfus, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 161) with videos related to
Sort By:
Page
of 17
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 8, 2024
A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome
Desiré Casares-Marfil, Manuel Martínez-Bueno, Maria Orietta Borghi, et al.
The Journal of Clinical Investigation
|
October 28, 2021
The intersection of COVID-19 and autoimmunity
Jason S Knight, Roberto Caricchio, Jean-Laurent Casanova, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 12, 2023
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study
Elena Gkrouzman, Rohan Willis, Danieli Andrade, et al.
The Journal of Clinical Investigation
|
June 13, 2024
Neutrophil glucose flux as a therapeutic target in antiphospholipid syndrome
Ajay Tambralli, Alyssa Harbaugh, Somanathapura K NaveenKumar, et al.
JCI Insight
|
August 22, 2023
Key patient demographics shape innate immune topography in noncritical hypoxic COVID-19 pneumonia
Allison C Billi, Rachael Wasikowski, Feiyang Ma, et al.
Frontiers in Immunology
|
April 27, 2026
Correction: A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry
Alexander Pine, Ayesha Butt, Laura Andreoli, et al.
Nature Communications
|
February 7, 2017
DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis
Nirit Mor-Vaknin, Anjan Saha, Maureen Legendre, et al.
Frontiers in Immunology
|
November 3, 2025
A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry
Alexander Pine, Ayesha Butt, Laura Andreoli, et al.
Arthritis Care & Research
|
April 19, 2018
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository
Ozan Unlu, Doruk Erkan, Medha Barbhaiya, et al.
The Journal of Experimental Medicine
|
April 18, 2020
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
Betsy J Barnes, Jose M Adrover, Amelia Baxter-Stoltzfus, et al.
Page
of 17